Deja Vu All Over Again - Sheffield Researcher Under Threat for Trying to Present Data that Offends Research Sponsor

It's deja vu all over again.  A case reported (so far only) in the UK Times Higher Education Supplement of a biomedical researcher appa...

Deja Vu All Over Again - Sheffield Researcher Under Threat for Trying to Present Data that Offends Research Sponsor 2015-05-13T01:04:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown

Effort to Make Health Insurance Reimbursement Fairer Lead by Director of Insurance Company Accused of Unfair Practices

We previously discussed a legal settlement of charges that UnitedHealth's Ingenix subsidiary manipulated its database of payments to ph...

Effort to Make Health Insurance Reimbursement Fairer Lead by Director of Insurance Company Accused of Unfair Practices 2015-05-12T19:57:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown

BLOGSCAN: CMSS New Ethics Code Analyzed

The Council of Medical Specialty Societies got some good press for its new code of ethics regarding medical associations' interaction wi...

BLOGSCAN: CMSS New Ethics Code Analyzed 2015-05-12T03:20:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown

Sanofi-Funded Society of Hospital Medicine Stands Up for Lovenox

Here is another case to raise questions about the true goal of some medical societies.  As reported by Alicia Mundy in the Wall Street Jour...

Sanofi-Funded Society of Hospital Medicine Stands Up for Lovenox 2015-05-07T20:19:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown

The Avandia Spin Cycle Continues Even After the FDA Safety Hearings

We have posted multiple times about Avandia (rosiglitazone), GlaxoSmithKline's star-crossed glucose-lowering drug.  While Avandia has re...

The Avandia Spin Cycle Continues Even After the FDA Safety Hearings 2015-05-07T18:50:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown

Again, Logical Fallacies in Defense of Conflicts of Interest: a Rebuttal to Rothman et al Appears in JACC

Earlier this year, a remarkable commentary in JAMA suggested major reconsideration of the relationships among professional medical associati...

Again, Logical Fallacies in Defense of Conflicts of Interest: a Rebuttal to Rothman et al Appears in JACC 2009-07-16T10:12:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown

Pharmacy Benefit Managers as Pharmaceutical Marketers

We posted a number of times about questionable practices Eli Lilly used to market its atypical anti-psychotic drug Zyprexa ( olanzapine ). ...

Pharmacy Benefit Managers as Pharmaceutical Marketers 2009-06-16T18:00:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown

A Letter from the RUC, and My Reply

The vast amounts spent in the US on health care have not translated into access for many patients, consistently excellent quality of care, a...

A Letter from the RUC, and My Reply 2009-06-10T11:35:00-07:00 Rating: 4.5 Diposkan Oleh: Unknown